Oxygen tension-dependent variability in the cancer cell kinome impacts signaling pathways and response to targeted therapies

被引:0
|
作者
Adebayo, Adedeji K. [1 ,2 ,3 ]
Bhat-Nakshatri, Poornima [1 ]
Davis, Christopher [4 ]
Angus, Steven P. [3 ,4 ]
Erdogan, Cihat [5 ]
Gao, Hongyu [5 ]
Green, Nick [5 ]
Kumar, Brijesh [1 ,7 ]
Liu, Yunlong [5 ]
Nakshatri, Harikrishna [1 ,2 ,3 ,6 ]
机构
[1] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Indiana Univ Simon Comprehens Canc Ctr, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA
[5] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[6] Roudebush VA Med Ctr, Indianapolis, IN 46202 USA
[7] Banaras Hindu Univ, Indian Inst Technol, Sch Biomed Engn, Varanasi 221005, Uttar Pradesh, India
基金
美国国家卫生研究院;
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR TYROSINE KINASE; MALIGNANT-TRANSFORMATION; THERAPEUTIC TARGET; TUMOR-CELLS; STEM; HYPOXIA; METASTASIS; ACTIVATION; EXPRESSION;
D O I
10.1016/j.isci.2024.110068
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Most cells in solid tumors are exposed to oxygen levels between 0.5% and 5%. We developed an approach that allows collection, processing, and evaluation of cancer and non -cancer cells under physioxia, while preventing exposure to ambient air. This aided comparison of baseline and drug -induced changes in signaling pathways under physioxia and ambient oxygen. Using tumor cells from transgenic models of breast cancer and cells from breast tissues of clinically breast cancer -free women, we demonstrate oxygen -dependent differences in cell preference for epidermal growth factor receptor (EGFR) or platelet -derived growth factor receptor beta (PDGFR b ) signaling. Physioxia caused PDGFR b- mediated activation of AKT and extracellular regulated kinase (ERK) that reduced sensitivity to EGFR and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) inhibition and maintained PDGFR b + epithelial-mesenchymal hybrid cells with potential cancer stem cell (CSC) properties. Cells in ambient air displayed differential EGFR activation and were more sensitive to targeted therapies. Our data emphasize the importance of oxygen considerations in preclinical cancer research to identify effective drug targets and develop combination therapy regimens.
引用
收藏
页数:24
相关论文
共 50 条
  • [41] Extensive Characterization of EGFR Pathways May Help in Integrating the Use of EGFR-Targeted Therapies in Patients with Squamous Cell Anal Cancer
    Martin, V.
    Zanellato, E.
    Molinari, F.
    Crippa, S.
    Bongiovanni, M.
    De Dosso, S.
    Franzetti-Pellanda, A.
    Movilia, A.
    Assi, A.
    Boldorini, R.
    Paganotti, A.
    Deantonio, L.
    Mazzucchelli, L.
    Saletti, P.
    Frattini, M.
    LABORATORY INVESTIGATION, 2011, 91 : 158A - 158A
  • [42] Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives
    Zhang, Hang
    Zhang, Yingying
    Zhu, Yingying
    Dong, Tian
    Liu, Zheng
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [43] ERBB2-Mutated Metastatic Non-Small Cell Lung Cancer: Response and Resistance to Targeted Therapies
    Chuang, Jody C.
    Stehr, Henning
    Liang, Ying
    Das, Millie
    Huang, Jane
    Diehn, Maximilian
    Wakelee, Heather A.
    Neal, Joel W.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (05) : 833 - 842
  • [44] EXTENSIVE CHARACTERIZATION OF EGFR PATHWAYS MAY HELP IN INTEGRATING THE USE OF EGFR-TARGETED THERAPIES IN PATIENTS WITH SQUAMOUS CELL ANAL CANCER
    De Dosso, S.
    Zanellato, E.
    Martin, V.
    Molinari, F.
    Movilla, A.
    Assi, A.
    Paganotti, A.
    Deantonio, L.
    Frattini, M.
    Saletti, P.
    ANNALS OF ONCOLOGY, 2010, 21 : 50 - 51
  • [45] Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy
    Rogers, Leann C.
    Davis, Ryan R.
    Said, Naveen
    Hollis, Thomas
    Daniel, Larry W.
    REDOX BIOLOGY, 2018, 15 : 380 - 386
  • [46] Targeting GPCR signaling in HER2+breast cancer suppresses cancer stem cell tumorigenicity and sensitizes HER2-targeted therapies
    Wang, Wei
    Bhargava, Dharmendra
    Ye, Yuan Chao
    Chen, Songhai
    CANCER RESEARCH, 2019, 79 (13)
  • [47] Pan-cancer analysis reveals that neurotrophin signaling correlates positively with anti-tumor immunity, clinical outcomes, and response to targeted therapies and immunotherapies in cancer
    Feng, Qiushi
    Song, Dandan
    Wang, Xiaosheng
    LIFE SCIENCES, 2021, 282
  • [48] Extensive Characterization of EGFR Pathways May Help in Integrating the Use of EGFR-Targeted Therapies in Patients with Squamous Cell Anal Cancer.
    Martin, V.
    Zanellato, E.
    Molinari, F.
    Crippa, S.
    Bongiovanni, M.
    De Dosso, S.
    Franzetti-Pellanda, A.
    Movilia, A.
    Assi, A.
    Boldorini, R.
    Paganotti, A.
    Deantonio, L.
    Mazzucchelli, L.
    Saletti, P.
    Frattini, M.
    MODERN PATHOLOGY, 2011, 24 : 158A - 158A
  • [49] DNA Damage Response Pathways and Cell Cycle Checkpoints in Colorectal Cancer: Current Concepts and Future Perspectives for Targeted Treatment
    Solier, S.
    Zhang, Y. -W.
    Ballestrero, A.
    Pommier, Y.
    Zoppoli, G.
    CURRENT CANCER DRUG TARGETS, 2012, 12 (04) : 356 - 371
  • [50] Investigation of oncogenic G-protein coupled receptor signaling pathways in Kras dependent pancreatic cancer cell lines
    Ocal, Ozhan
    MacDonald, Raymond
    Brekken, Rolf A.
    Wilkie, Thomas
    FASEB JOURNAL, 2019, 33